- Home
- ULH vs LAB Comparison
ULH vs LAB Comparison
Compare ULH & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- LAB
- Stock Information
- Founded
- ULH 1932
- LAB 1999
- Country
- ULH United States
- LAB United States
- Employees
- ULH N/A
- LAB N/A
- Industry
- ULH Trucking Freight/Courier Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- ULH Industrials
- LAB Industrials
- Exchange
- ULH Nasdaq
- LAB Nasdaq
- Market Cap
- ULH 618.7M
- LAB 504.2M
- IPO Year
- ULH 2005
- LAB 2011
- Fundamental
- Price
- ULH $19.04
- LAB $1.27
- Analyst Decision
- ULH Hold
- LAB Buy
- Analyst Count
- ULH 1
- LAB 2
- Target Price
- ULH $24.00
- LAB $2.50
- AVG Volume (30 Days)
- ULH 52.8K
- LAB 1.4M
- Earning Date
- ULH 10-23-2025
- LAB 11-11-2025
- Dividend Yield
- ULH 2.21%
- LAB N/A
- EPS Growth
- ULH N/A
- LAB N/A
- EPS
- ULH 2.31
- LAB N/A
- Revenue
- ULH $1,668,148,000.00
- LAB $172,271,000.00
- Revenue This Year
- ULH N/A
- LAB N/A
- Revenue Next Year
- ULH $5.57
- LAB N/A
- P/E Ratio
- ULH $8.24
- LAB N/A
- Revenue Growth
- ULH N/A
- LAB 76.33
- 52 Week Low
- ULH $18.40
- LAB $0.92
- 52 Week High
- ULH $53.29
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- ULH 33.68
- LAB 46.31
- Support Level
- ULH $18.50
- LAB $1.28
- Resistance Level
- ULH $19.71
- LAB $1.47
- Average True Range (ATR)
- ULH 1.17
- LAB 0.08
- MACD
- ULH -0.22
- LAB -0.00
- Stochastic Oscillator
- ULH 13.06
- LAB 11.36
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.